194 related articles for article (PubMed ID: 35663307)
1. TEMPI Syndrome: Update on Clinical Features, Management, and Pathogenesis.
Xu J; Liu W; Fan F; Zhang B; Zhao F; Hu Y; Sun C
Front Endocrinol (Lausanne); 2022; 13():886961. PubMed ID: 35663307
[TBL] [Abstract][Full Text] [Related]
2. TEMPI Syndrome: Erythrocytosis in Plasma Cell Dyscrasia.
Zhang X; Fang M
Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):724-730. PubMed ID: 30100329
[TBL] [Abstract][Full Text] [Related]
3. The TEMPI syndrome.
Sykes DB; O'Connell C; Schroyens W
Blood; 2020 Apr; 135(15):1199-1203. PubMed ID: 32108223
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Next-Generation Sequencing Testing in a Patient with TEMPI Syndrome.
Nunes Rosado FG; Lekovic D; Gagan J; Malter J; Chen W; Sykes DB
Lab Med; 2023 Sep; 54(5):546-549. PubMed ID: 36864546
[TBL] [Abstract][Full Text] [Related]
5. TEMPI syndrome: A clinical, light-microscopic and phenotypic evaluation with review of the literature.
Kalomeris TA; Grossman ME; Tepler J; Magro CM
J Cutan Pathol; 2024 Apr; 51(4):299-305. PubMed ID: 38102936
[TBL] [Abstract][Full Text] [Related]
6. Whole-genome sequencing suggests a role of MIF in the pathophysiology of TEMPI syndrome.
Sun C; Xu J; Zhang B; Huang H; Chen L; Yan H; Xu A; Zhao F; Huang D; Liu L; Li J; Hu Y
Blood Adv; 2021 Jun; 5(12):2563-2568. PubMed ID: 34129019
[TBL] [Abstract][Full Text] [Related]
7. Case report: a 37-year-old male with telangiectasias, polycythemia vera, perinephric fluid collections, and intrapulmonary shunting.
Khan J; Sykes DB
BMC Hematol; 2014; 14(1):11. PubMed ID: 25143825
[TBL] [Abstract][Full Text] [Related]
8. The First Case of TEMPI Syndrome in Japan.
Shizuku T; Matsui K; Yagi S; Iwabuchi S
Intern Med; 2020 Jul; 59(14):1741-1744. PubMed ID: 32295999
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow findings of the newly described TEMPI syndrome: when erythrocytosis and plasma cell dyscrasia coexist.
Rosado FG; Oliveira JL; Sohani AR; Schroyens W; Sykes DB; Kenderian SS; Lacy MQ; Kyle RA; Hoyer JD
Mod Pathol; 2015 Mar; 28(3):367-72. PubMed ID: 25216227
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Complete Clinical and Hematological Response With Bortezomib: The Report of a Case With TEM(P)I Syndrome and a Review of the Literature.
Undar L; Atas U; Iltar U; Salim O; Yucel OK; Alpsoy E
Clin Lymphoma Myeloma Leuk; 2022 Sep; 22(9):702-707. PubMed ID: 35624059
[TBL] [Abstract][Full Text] [Related]
11. A rare case of TEMPI syndrome (telangiectasias, erythrocytosis, monoclonal gammopathy and ascites) associated with IgM monoclonal gammopathy.
Asimakopoulou S; Malandrakis P; Kamiliou A; Gavriatopoulou M; Bafa K; Samaras V; Anastasopoulou A; Variami E; Lakiotaki E; Korkolopoulou P; Kastritis E; Dimopoulos MA; Cholongitas E
Leuk Lymphoma; 2024 Jun; 65(6):857-859. PubMed ID: 38419349
[No Abstract] [Full Text] [Related]
12. Case Report: TEMPI syndrome: Report of three cases and treatment follow-up.
Xu ZF; Ruan J; Chang L; Wu S; Lin J; Wang W; Cao X; Zhang L; Li J; Zhou D; Zhang W
Front Oncol; 2022; 12():949647. PubMed ID: 35992844
[TBL] [Abstract][Full Text] [Related]
13. A fatal case of TEMPI syndrome, refractory to proteasome inhibitors and autologous stem cell transplantation.
Diral E; Parma M; Renso R; Pezzatti S; Terruzzi E; Perfetti P; D'Aliberti D; Gambacorti-Passerini C; Piazza R; Elli EM
Leuk Res; 2020 Oct; 97():106441. PubMed ID: 32861019
[No Abstract] [Full Text] [Related]
14. Complete Remission in a TEMPI Syndrome Treated with a Daratumumab, Lenalidomide, and Dexamethasone-Based Regimen: A Case Report.
Sansen PY; Montfort L; Nanquette A; Depaus J; Vellemans H
Case Rep Oncol; 2024; 17(1):175-179. PubMed ID: 38298466
[TBL] [Abstract][Full Text] [Related]
15. Coexistence of TEMPI syndrome and leukocytoclastic vasculitis successfully treated with autologous stem cell transplantation.
Nappi D; Tauber M; Sykes D
EJHaem; 2022 Nov; 3(4):1385-1387. PubMed ID: 36467823
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous bortezomib for treatment of TEMPI syndrome.
Jasim S; Mahmud G; Bastani B; Fesler M
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):e221-3. PubMed ID: 25172534
[No Abstract] [Full Text] [Related]
17. Cutaneous manifestations of monoclonal gammopathy.
Claveau JS; Wetter DA; Kumar S
Blood Cancer J; 2022 Apr; 12(4):58. PubMed ID: 35411042
[TBL] [Abstract][Full Text] [Related]
18. Difficulties in hematopoietic progenitor cell collection from a patient with TEMPI syndrome and severe iatrogenic iron deficiency.
Belizaire R; Sykes DB; Chen YB; Spitzer TR; Makar RS
Transfusion; 2015 Sep; 55(9):2142-8. PubMed ID: 25911963
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal gammopathy of clinical significance: what the rheumatologist needs to know.
Marinkovic A; Zypchen LN; Chan J; Chen LY; Parkin S
Lancet Rheumatol; 2022 May; 4(5):e362-e373. PubMed ID: 38294033
[TBL] [Abstract][Full Text] [Related]
20. TEMPI Syndrome With Progressive Telangiectasias Associated With Pulmonary Deterioration.
Lor M; Cheng M; Liang B; Cheng CE
JAMA Dermatol; 2020 Dec; 156(12):1379-1380. PubMed ID: 32845290
[No Abstract] [Full Text] [Related]
[Next] [New Search]
